stableImportance 4/5Confidence 5/51 documented update

Trump’s pharma tariff order is a maze of delays, carve-outs and company-specific rates

The White House’s April 2 pharmaceutical proclamation sets a 100% duty on certain patented drugs and ingredients, but the main tariff provisions do not hit all at once. Annex III companies face the first effective date, July 31, 2026, while other companies fall under the later September 29, 2026 start, and several products and negotiated lanes are carved out entirely.

Why it matters: Tariff carve-out maze

First recorded Apr 16, 2026·Meaningfully updated Apr 16, 2026

Returning reader

What changed

Trump’s pharma tariff order is a maze of delays, carve-outs and company-specific rates

The White House’s April 2 pharmaceutical proclamation sets a 100% duty on certain patented drugs and ingredients, but the main tariff provisions do not hit all at once. Annex III companies face the first effective date, July 31, 2026, while other companies fall under the later September 29, 2026 start, and several products and negotiated lanes are carved out entirely.

Read the complete verified update

Complete record

Timeline

Newest first

Confidence 5/5

Trump’s pharma tariff order is a maze of delays, carve-outs and company-specific rates

The White House’s April 2 pharmaceutical proclamation sets a 100% duty on certain patented drugs and ingredients, but the main tariff provisions do not hit all at once. Annex III companies face the first effective date, July 31, 2026, while other companies fall under the later September 29, 2026 start, and several products and negotiated lanes are carved out entirely.

Truth standard

What TDF can prove

The linked reports preserve their sources, audit notes, confidence rating, corrections, and comments. The page Q&A below is restricted to those connected materials and will say when the evidence does not establish an answer.